DENDREON CORP·4

Jul 19, 2:50 PM ET

DENDREON CORP 4

4 · DENDREON CORP · Filed Jul 19, 2011

Insider Transaction Report

Form 4
Period: 2011-07-15
URDAL DAVID
SVP, Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2011-07-17$38.43/sh2,035$78,205577,095 total
  • Sale

    Common Stock

    2011-07-15$39.19/sh5,312$208,177579,130 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person

Documents

2 files
  • 4
    c20071_4x1.xmlPrimary

    MAIN DOCUMENT DESCRIPTION

  • EX-24

    POWER OF ATTORNEY